Jaguar Health shares are trading lower after the company reported a year-over-year decrease in Q4 EPS results and worse-than-expected revenue results.
Portfolio Pulse from Benzinga Newsdesk
Jaguar Health's stock is trading lower following the announcement of a decrease in Q4 EPS and revenue results that fell below expectations.
April 01, 2024 | 4:32 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Jaguar Health's shares are down due to disappointing Q4 earnings and revenue results.
The decrease in Q4 EPS and worse-than-expected revenue results directly impact investor sentiment and the stock's value, leading to a decrease in share price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100